GRI Bio, Inc. Common Stock (GRI) is a publicly traded Healthcare sector company. As of May 21, 2026, GRI trades at $2.23 with a market cap of $3.09M and a P/E ratio of -0.02. GRI moved -0.45% today. Year to date, GRI is -74.50%; over the trailing twelve months it is -94.58%. Its 52-week range spans $1.97 to $852.04. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces GRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GRI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.23 |
| Market Cap | $3.09M |
| P/E Ratio | -0.02 |
| EPS | $-121.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $852.04 |
| 52-Week Low | $1.97 |
| Volume | 50 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.96M |
| Gross Margin | 0.00% |
2 analysts cover GRI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.